Insider Shareholders with Direct Ownership of Pmv Pharmaceuticals, Inc. (PMVP)
This section provides a comprehensive overview of the insiders with direct ownership of Pmv Pharmaceuticals, Inc. (PMVP). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
PMV Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Interwest Partners X Lp
> 10% Shareholder |
0 | 2,000,000 | 4,469,911 $5.94 Million | 3 |
Jul 13, 2021
Reduced 10.06%
|
| 2,268,236 | 0 | 2,268,236 $3.02 Million | 2 |
Sep 29, 2020
Added 24.4%
|
|
|
David Henry Mack
President and CEO |
679,226 | 185,718 | 536,133 $713,056 | 22 |
Jul 01, 2025
Reduced 9.82%
|
| 0 | 17,500 | 409,842 $545,089 | 5 |
Sep 22, 2021
Reduced 0.85%
|
|
|
Robert Ticktin
General Counsel & COO |
0 | 23,151 | 98,695 $131,264 | 1 |
Jul 01, 2025
Reduced 19.0%
|
|
Deepika Jalota
Chief Development Officer |
132,501 | 47,283 | 89,959 $119,645 | 7 |
Jul 01, 2025
Reduced 26.88%
|
|
Michael Carulli
Chief Financial Officer |
82,220 | 31,140 | 60,146 $79,994 | 3 |
Jul 01, 2025
Reduced 31.96%
|
|
Leila Alland
Chief Medical Officer |
76,200 | 30,762 | 45,909 $61,058 | 16 |
Sep 15, 2023
Reduced 12.05%
|
|
Winston Kung
COO, CFO |
28,600 | 23,285 | 10,600 $14,098 | 13 |
Nov 25, 2022
Reduced 19.45%
|